A Phase II Study on the Duration and Stability of the Intraocular Pressure-Lowering Effect and Tolerability of Tafluprost Compared With Latanoprost-Reference-Cited by-同舟云学术

A Phase II Study on the Duration and Stability of the Intraocular Pressure-Lowering Effect and Tolerability of Tafluprost Compared With Latanoprost

Published:2010-02 Issue:1 Volume:26 Page:97-104
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Traverso Carlo E.¹,Ropo Auli²,Papadia Marina¹,Uusitalo Hannu³⁴

Affiliation:

1. Centro di Ricerca Clinica e Laboratorio per il Glaucoma e la Cornea, DiNOG, Clinica Oculistica University of Genova, Azienda Ospedaliera Universitaria San Martino, Genova, Italy.

2. Santen Oy, Clinical Research, Helsinki, Finland.

3. University of Kuopio, Kuopio, Finland.

4. University of Tampere and Tampere University Hospital, Tampere, Finland.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2009.0066

Reference21 articles.

1. The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration

2. Factors for Glaucoma Progression and the Effect of Treatment

3. The Ocular Hypertension Treatment Study

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network meta-analysis made simple: a composite likelihood approach;2024-06-20

2. Chemical Insights into Topical Agents in Intraocular Pressure Management: From Glaucoma Etiopathology to Therapeutic Approaches;Pharmaceutics;2024-02-15

3. Efficacy of preserved Tafluprost 0.0015% in lowering intraocular pressure;Indian Journal of Ophthalmology;2023-11-20

4. Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions;Pharmaceuticals;2023-07-24

5. Effects of Tafluprost on Ocular Blood Flow;Ophthalmology and Therapy;2022-09-15